Larvol Delta - Axovia-Therapeutics-Presents-New-Preclinical-Data-for-AXV101-for-the-Treatment-of-Blindness-Associated-with-BBS-Mutations-at-ASGCT

AXV-101 - Axovia Therap

https://www.globenewswire.com/news-release/2025/05/13/3079937/0/en/Axovia-Therapeutics-Presents-New-Preclinical-Data-for-AXV-101-for-the-Treatment-of-Blindness-Associated-with-BBS-Mutations-at-ASGCT.html

May 13, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next